These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 15085809)

  • 1. New Zealand launches biotech seed fund.
    Griggs K
    Nat Biotechnol; 2004 Apr; 22(4):480-1. PubMed ID: 15085809
    [No Abstract]   [Full Text] [Related]  

  • 2. Portugal opens its borders to biotechnology.
    Louët S
    Nat Biotechnol; 2000 Mar; 18(3):276-7. PubMed ID: 10700139
    [No Abstract]   [Full Text] [Related]  

  • 3. How the US government can fund your company.
    Basu P
    Nat Biotechnol; 2004 Apr; 22(4):482-6. PubMed ID: 15085814
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotech marks time in Q3.
    Lawrence S
    Nat Biotechnol; 2005 Nov; 23(11):1332. PubMed ID: 16273049
    [No Abstract]   [Full Text] [Related]  

  • 5. The 20-year African biotech plan.
    Singh JA; Daar AS
    Nat Biotechnol; 2008 Mar; 26(3):272-4. PubMed ID: 18327231
    [No Abstract]   [Full Text] [Related]  

  • 6. Chile launches policy to boost biotech.
    Orellana C
    Nat Biotechnol; 2004 Jan; 22(1):7-8. PubMed ID: 14704689
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotech sector ponders potential 'bloodbath'.
    Mitchell P
    Nat Biotechnol; 2009 Jan; 27(1):3-4. PubMed ID: 19131974
    [No Abstract]   [Full Text] [Related]  

  • 8. New law to boost French biotech industry.
    Louët S
    Nat Biotechnol; 1999 Nov; 17(11):1055. PubMed ID: 10545900
    [No Abstract]   [Full Text] [Related]  

  • 9. Biotechnology venture capital booms in Japan.
    Saegusa A
    Nat Biotechnol; 2000 Mar; 18(3):256. PubMed ID: 10700128
    [No Abstract]   [Full Text] [Related]  

  • 10. Perspective: A tale of 'cautious pessimism': Biotechnology, recession and the 'new economy'.
    Kewell B; Webster A
    Biotechnol J; 2009 Aug; 4(8):1106-8. PubMed ID: 19685467
    [No Abstract]   [Full Text] [Related]  

  • 11. OECD says industrial biotech not realizing potential.
    Niiler E
    Nat Biotechnol; 2001 Jun; 19(6):493-4. PubMed ID: 11385413
    [No Abstract]   [Full Text] [Related]  

  • 12. Share slump brings biotech firms to government's door.
    Check E
    Nature; 2003 Jun; 423(6943):908. PubMed ID: 12827159
    [No Abstract]   [Full Text] [Related]  

  • 13. Materials exchange deal meager boost to India's biotech.
    Jayaraman KS
    Nat Biotechnol; 2005 Sep; 23(9):1031. PubMed ID: 16151380
    [No Abstract]   [Full Text] [Related]  

  • 14. Ireland embraces biotechnology.
    Canning S
    Nat Biotechnol; 2000 Mar; 18(3):273-5. PubMed ID: 10700138
    [No Abstract]   [Full Text] [Related]  

  • 15. German regions compete for biotech funds.
    Abbott A; Schiermeir Q
    Nature; 1996 Feb; 379(6568):759. PubMed ID: 8587590
    [No Abstract]   [Full Text] [Related]  

  • 16. Australian states compete for biotech primacy.
    Norrie C
    Nat Biotechnol; 2002 Aug; 20(8):760. PubMed ID: 12147988
    [No Abstract]   [Full Text] [Related]  

  • 17. Plan for $100m boost to Israeli biotech comes under threat.
    Watzman H
    Nature; 1998 Mar; 392(6672):117. PubMed ID: 9515950
    [No Abstract]   [Full Text] [Related]  

  • 18. Fickle financing climate continues.
    Mitchell P
    Nat Biotechnol; 2001 Aug; 19(8):695-6. PubMed ID: 11479542
    [No Abstract]   [Full Text] [Related]  

  • 19. Putting a price on biotechnology.
    Stewart JJ; Allison PN; Johnson RS
    Nat Biotechnol; 2001 Sep; 19(9):813-7. PubMed ID: 11533634
    [No Abstract]   [Full Text] [Related]  

  • 20. Funding bonanza for astronomy and biotech in Australia.
    Pockley P
    Nature; 2001 Aug; 412(6850):846. PubMed ID: 11528440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.